-
Cell Counting Kit-8 Plus: 5 Lab Scenarios
2026-08-19
This scenario-driven guide explains how Cell Counting Kit-8 (CCK-8) Plus, SKU K2268, can improve WST-8-based viability, proliferation, and cytotoxicity workflows. It covers assay interpretation, controls, protocol optimization, data quality, and practical vendor selection for biomedical laboratories.
-
Latrunculin A for Actin Dynamics Research
2026-08-18
Latrunculin A provides a reversible way to interrogate how actin assembly shapes growth-cone behavior, cell morphology, and motility. This guide translates stiffness-dependent DRG axon findings into practical perturbation, imaging, washout, and troubleshooting workflows without conflating actin inhibition with Piezo1-specific biology.
-
GSK3 Inhibition as Host-Directed TB Therapy
2026-08-18
The iScience study identifies glycogen synthase kinase 3 as a host determinant that supports intracellular Mycobacterium tuberculosis growth. By combining pharmacological screening with CRISPR, RNA interference, apoptosis analysis, and phosphoproteomics, the authors provide a mechanistic basis for developing host-directed tuberculosis therapies alongside conventional antimicrobials.
-
YC-1 Workflow for HIF-1α Hypoxia Research
2026-08-17
YC-1 is a dual-purpose research probe for connecting HIF-1α-dependent hypoxia responses with soluble guanylyl cyclase signaling. This workflow translates a recent neural-injury study into practical cell, tissue, and mechanistic assays while emphasizing solvent control, pathway-specific interpretation, and reproducible dosing.
-
H-89 for PKA Signaling and Osteogenesis Research
2026-08-17
H-89 provides a practical pharmacological entry point for testing how PKA contributes to Wnt-driven metabolic and osteogenic responses. This workflow-oriented guide connects dose and timing control with glycolysis, O-GlcNAcylation, proliferation, and apoptosis readouts while emphasizing selectivity limits and essential controls.
-
Trifluoperazine 2HCl: Research Workflows
2026-08-16
Build mechanism-resolved assays around Trifluoperazine 2HCl, from dopamine D2 receptor signaling to macrophage autophagy, ROS, and cancer phenotypes. Practical dosing, stock-preparation, controls, and troubleshooting guidance help distinguish target-linked biology from exposure or cytotoxicity artifacts.
-
Mitochondrial CAT-Tailing in Glioblastoma Growth
2026-08-15
Zhang, Cai et al. identify mitochondrial stress-induced carboxyl-terminal alanine-threonine tailing as a ribosome-associated quality-control response that supports glioblastoma survival, migration, and overgrowth. Their experiments connect CAT-tailed mitochondrial proteins, ATP synthase function, mitochondrial membrane potential, permeability transition, and apoptosis resistance, while suggesting that this pathway may be therapeutically tractable.
-
Injectable GelMA/QCS/Ca²⁺ Adhesive for Hemostasis
2026-08-14
The reference study develops an injectable GelMA/QCS/Ca²⁺ double-network adhesive that combines blue-light-triggered sealing with quaternary ammonium chitosan-mediated antibacterial functionality. Across laboratory and mouse injury models, the material improved hemostatic and antibacterial performance relative to fibrin glue and single-function hydrogels, supporting its investigation for non-compressible hemorrhage.
-
Caspase-3–NDUFS1 Axis in Trichothecene ROS
2026-08-14
This preprint identifies caspase-3-mediated cleavage of the mitochondrial complex I subunit NDUFS1 as a mechanistic driver of reactive oxygen species accumulation after DON or T-2 toxin exposure. It also places ERO1α-dependent endoplasmic reticulum stress in a positive feedback loop with mitochondrial injury, providing a more integrated model of trichothecene-induced hepatotoxicity.
-
LG 101506: Designing RXR Mechanism Studies
2026-08-13
LG 101506 is an RXR modulator for separating receptor-driven transcription from RBMS1–B4GALT1–PD-L1 biology in immune-cold tumor models. This article presents an assay-centered framework for RXR signaling pathway research, experimental controls, and translational interpretation.
-
Sex Differences in Angiotensin II Hypertension
2026-08-13
The reference study used telemetry in conscious, freely moving mice to show that chronic angiotensin II produces a much larger hypertensive response in males than females. Gonadectomy and autonomic intervention further connected this sex difference to hormone-dependent and sympathetic mechanisms, providing a useful framework for hypertension and autonomic nervous system studies.
-
PEGylated Iron Oxide Nanoparticles in the Liver
2026-08-12
This ACS Nano study systematically separates the effects of iron oxide nanoparticle size and PEG chain length on hepatic distribution and cell-specific uptake. Its combination of 99mTc SPECT/CT with primary liver-cell assays shows that hepatocytes and stellate cells can contribute substantially to uptake, challenging the assumption that Kupffer cells dominate nanoparticle clearance.
-
Nitroaromatic Nannocystin Targets AKT1 in Colorectal Cancer
2026-08-12
This 2024 Acta Pharmacologica Sinica study combined improved macrocycle synthesis, phenotypic screening, patient-derived organoids, and xenograft testing to characterize a nitroaromatic nannocystin, compound 4, as a potent colorectal cancer inhibitor. Its data support AKT1 engagement as part of the mechanism and provide a useful framework for connecting antiproliferative activity with apoptosis, senescence, and translational tumor models.
-
12-O-tetradecanoyl phorbol-13-acetate Workflows
2026-08-11
Build reproducible PKC-to-ERK/MAPK experiments with 12-O-tetradecanoyl phorbol-13-acetate (TPA), from rapid phosphoprotein assays to skin cancer models. A practical workflow connects dose timing, solvent control, orthogonal macrophage experiments, and troubleshooting so pathway activation is interpretable rather than merely detectable.
-
SCH772984: ERK1/2 Inhibitor Workflow
2026-08-11
Build a reproducible SCH772984 workflow for mapping ERK signaling, testing MAPK-driven tumor phenotypes, and exploring radiosensitivity in nasopharyngeal carcinoma models. Practical dosing, assay-selection, storage, and troubleshooting guidance helps distinguish direct pathway suppression from downstream stress effects.